US BROKER MOVES: SHOP upgraded at Jefferies; PZZA downgraded at BofA
Brokerages issued numerous rating changes today, highlighting upgrades for Shopify and American Express, while downgrading Papa John's and initiating coverage on Disney with a Buy rating.
News detail
UPGRADES Atlanticus Holdings (ATLC) Upgraded to Buy at Texas Capital Securities; PT USD 144 (prev USD 100) American Express (AXP) Upgraded to Overweight at JPMorgan; PT USD 400 (prev USD 328) Biogen (BIIB) Upgraded to Buy at Truist Securities; PT USD 235 Casey’s General Stores (CASY) Upgraded to Buy at Northcoast; PT USD 950 Capital One Financial (COF) Upgraded to Buy at HSBC; PT USD 229 (prev USD 226) Deckers Outdoor (DECK) Upgraded to Buy at Jefferies; PT USD 130 (prev USD 110) Humana (HUM) Upgraded to Overweight at Wells Fargo; PT USD 502 (prev USD 227) Keysight Technologies (KEYS) Upgraded to Overweight at Morgan Stanley; PT USD 400 (prev USD 350) NIO (NIO) Upgraded to Buy at Goldman Sachs; PT USD 7 ON Semiconductor (ON) Upgraded to Buy at Jefferies; PT USD 380 (prev USD 333) Saia (SAIA) Upgraded to Buy at BofA Securities; PT USD 502 (prev USD 499) Shopify (SHOP) Upgraded to Buy at Jefferies; PT USD 160 (prev USD 140) Solesence (SOLS) Upgraded to Buy at UBS; PT USD 78 (prev USD 88) Verra Mobility (VRRM) Upgraded to Neutral at JPMorgan; PT USD 6 (prev USD 5) DOWNGRADES Best Buy (BBY) Downgraded to Hold at Loop Capital Porch Group (PRCH) Downgraded to Market Perform at Keefe, Bruyette & Woods; PT USD 16.25 (prev USD 13) Papa John’s International (PZZA) Downgraded to Underperform at BofA Securities; PT USD 34 (prev USD 42) ResMed (RMD) Downgraded to Neutral at Citi; PT USD 235 (prev USD 270) Sezzle (SEZL) Downgraded to Market Perform at Keefe, Bruyette & Woods; PT USD 190 Sun Life Financial (SLF) Downgraded to In Line at Evercore ISI Travelers Companies (TRV) Downgraded to Sell at TD Cowen; PT USD 297 INITIATIONS Alkermes (ALKS) Initiated Neutral at JPMorgan; PT USD 60 Apyx Medical (APYX) Initiated Buy at H.C. Wainwright; PT USD 7 Atmos Energy (ATO) Initiated Overweight at Wells Fargo; PT USD 200 BioCryst Pharmaceuticals (BCRX) Initiated Neutral at JPMorgan; PT USD 12 Bel Fuse (BELFB) Initiated Buy at Citi; PT USD 325 BrightSpring Health Services (BTSG) Initiated Buy at Guggenheim; PT USD 81 Candel Therapeutics (CADL) Initiated Buy at Stifel; PT USD 22 Cellectar Biosciences (CLRB) Initiated Buy at Brookline Capital Markets; PT USD 15 Costco Wholesale (COST) Initiated Sector Perform at RBC Capital; PT USD 1,000 Walt Disney (DIS) Initiated Buy at Benchmark; PT USD 115 Denali Therapeutics (DNLI) Initiated Overweight at JPMorgan; PT USD 29 Equillium (EQ) Initiated Overweight at Piper Sandler; PT USD 20 Fastenal (FAST) Initiated Buy at Rothschild Redburn; PT USD 55 First Community Bankshares (FCBM) Initiated Outperform at Keefe, Bruyette & Woods; PT USD 15 First Community Bankshares (FCBM) Initiated Outperform at Raymond James; PT USD 15 GE Vernova (GEV) Initiated Hold at Fubon; PT USD 1,205 Honeywell (HON) Initiated In Line at Evercore ISI; PT USD 250 Legend Biotech (LEGN) Initiated Neutral at JPMorgan; PT USD 35 MDU Resources (MDU) Initiated Overweight at Wells Fargo; PT USD 25 MSC Industrial Direct (MSM) Initiated Buy at Rothschild Redburn; PT USD 155 NuVasive / Novocure (NVCR) Initiated Neutral at JPMorgan; PT USD 17 Park Aerospace (PKE) Initiated Buy at Needham; PT USD 43 Praxis Precision Medicines (PRAX) Initiated Buy at Goldman Sachs; PT USD 447 SiteOne Landscape Supply (SITE) Initiated Overweight at KeyBanc; PT USD 145 Stoke Therapeutics (STOK) Initiated Buy at Goldman Sachs; PT USD 44 Whirlpool (WHR) Initiated Neutral at BNP Paribas Exane West Pharmaceutical Services (WST) Initiated Outperform at BNP Paribas Exane; PT USD 447
Related stocks
46 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
